Campylobacter jejuni HS:23 and Guillain-Barré Syndrome, Bangladesh

Emerging Infectious Diseases

Volumn 15, Issue 8, 2009, Pages 1315-1317

  Islam, Zhahirul ^a,b   Van Belkum, Alex ^b   Cody, Alison J ^c   Tabor, Helen ^d   Jacobs, Bart C ^b   Talukder, Kaisar A ^a   Endtz, Hubert P ^a,b  

^a ICDDRB Laboratory Sciences Division   (Bangladesh)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VIRULENCE; BANGLADESH; CAMPYLOBACTER JEJUNI; CASE CONTROL STUDY; CONTROLLED STUDY; GENETIC VARIABILITY; GENOTYPE; GUILLAIN BARRE SYNDROME; HUMAN; LETTER; MAJOR CLINICAL STUDY; MULTILOCUS SEQUENCE TYPING; NONHUMAN; SEROTYPE;

BANGLADESH; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; COMMUNICABLE DISEASES, EMERGING; FEMALE; GASTROENTERITIS; GENOTYPE; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; PROSPECTIVE STUDIES; SEROTYPING; VIRULENCE;

EID: 68049104250     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1508.090120     Document Type: Letter

References (10)

1. Winer JB. Guillain-Barré syndrome. BMJ. 2008;337:a671. DOI: 10.1136/bmj.a671
2. Wassenaar TM, Fry BN, Lastovica AJ, Wagenaar JA, Coloe PJ, Duim B. Genetic characterization of Campylobacter jejuni O:41 isolates in relation with Guillain-Barré syndrome. J Clin Microbiol. 2000;38:874-6.
3. Nachamkin I, Allos BM, Ho T. Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev. 1998;11:555-67.
4. Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, et al. Comprehensive analysis of bacterial risk factors for the development of Guillain-Barré syndrome after Campylobacter jejuni enteritis. J Infect Dis. 2006;193:547-55. DOI: 10.1086/499969
5. Endtz HP, Ang CW, van Den Braak N, Duim B, Rigter A, Price LJ,et al. Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes. J Clin Microbiol. 2000;38:2297-301.
6. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol. 1990;27:S21-4. DOI: 10.1002/ana.410270707
7. Penner JL, Hennessy JN, Congi RV. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur J Clin Microbiol. 1983;2:378-83. DOI: 10.1007/ BF02019474
8. Godschalk PC, Heikema AP, Gilbert M, et al. The crucial role of Campylobacter jejuni genes in anti-ganglioside antibody induction in Guillain-Barré syndrome. J Clin Invest. 2004;114:1659-65.
9. Nachamkin I, Engberg J, Gutacker M, Meinersman RJ, Li CY, Arzate P, et al. Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis. 2001;184:221-6. DOI: 10.1086/322008
10. Parker CT, Horn ST, Gilbert M, Miller WG, Woodward DL, Mandrell RE. Comparison of Campylobacter jejuni lipooligosaccharide biosynthesis loci from a variety of sources. J Clin Microbiol. 2005;43:2771-81.